Funding from the European Union

Denna sida på svenska

The European Union (EU) is the largest international funding organisation for research at Karolinska Institutet.

Grants from the EU

KI is the largest recipient of EU grants of all Swedish research institutions, and the fourth largest in Europe in the field of Health. KI also participates in projects within the programs for food, information and communication technology, nanoscience, safety and environment.


European collaborative projects

European collaborative projects at KI are funded by the Seventh Frame Programme (FP7), Horizion 2020, by the joint effort of the EU Commission and pharma industry called Innovative Medicines Initiative (IMI), and also by the EU Joint Programme Neurodegenerative Disease Research (JPND).

In 2016, KI participated in 198 EU projects and coordinated 11 of these. KI participates in 14 of the ongoing IMI projects, of which one as a coordinator. KI is also involved in four projects within EU's Third Health Programme. 

EU projects at KI 2010-2016              
  2010 2011 2012 2013 2014 2015 2016
Total number of projects 204 222 234 229 202 214 198
– with KI as coordinator 29 31 21 19 15 12 11

ERC Grants

European funding to individual researchers at KI mainly comes from the European Research Council (ERC) or the Research Executive Agency (REA).  In 2016, ten new projects started with support from ERC. By the end of 2016 there were 33 active ERC projects at KI. 

Individual Marie Curie Grants

Marie Curie is the collective name for the EU Commission's programme addressed to research career development. There are two main types of Marie Curie Programmes, individual fellowships and network grants. Karolinska Institutet has in recent years been quite successful in the competition for individual Marie Curie fellowships.

EIT Health

EIT Health is a new innovation initiative focusing on healthy living and active aging. EIT Health is co-funded by the European Institute of Innovation and Technology, EIT, which in turn is an EU-funded initiative to stimulate collaboration between academic research and industry. KI is one of the players in this major European research consortium concentrated in seven centers, or so-called nodes, in Europe. The goal with EIT Health is to contribute to increasing the competitiveness of European industry, improve the quality of life of Europe’s citizens and the sustainability of healthcare system.